Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial
Arvind Chopra, Girish Tillu, Kuldeep Chuadhary, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282688-e0282688
Open Access | Times Cited: 20

Showing 20 citing articles:

Perspectives on nano-nutraceuticals to manage pre and post COVID-19 infections
Ankit Kumar Dubey, Suman Kumar Chaudhry, Harikesh Bahadur Singh, et al.
Biotechnology Reports (2022) Vol. 33, pp. e00712-e00712
Open Access | Times Cited: 29
AYUSH- 64: A potential therapeutic agent in COVID-19
Ashok Kumar Panda, Sarbeswar Kar, Amit Kumar, et al.
Journal of Ayurveda and Integrative Medicine (2022) Vol. 13, Iss. 2, pp. 100538-100538
Open Access | Times Cited: 28
AYUSH-64 Modulates Th17/Treg Balance to Attenuate LPS-Induced Inflammation in Cell-Based Assays and BALB/c Mice Model
M. Geetha Priya, Pavan Reddy, Yamini Goswami, et al.
Pharmacological Research - Natural Products (2025), pp. 100159-100159
Closed Access
Exploring Natural Plant Compounds Against the SARS-CoV-2 Spike Protein: An Analytical and Computational Approach for Drug Discovery
Neelanjan Chowdhury, Suraj Sakharam Kutre, Pethakamsetti Mounika Sai, et al.
Pharmacological Research - Natural Products (2025), pp. 100191-100191
Closed Access
AYUSH-64 as an adjunct to standard care in mild to moderate COVID-19: An open-label randomized controlled trial in Chandigarh, India
Harbans Singh, Sumit Srivastava, Babita Yadav, et al.
Complementary Therapies in Medicine (2022) Vol. 66, pp. 102814-102814
Open Access | Times Cited: 24
Ayurvedic Medicine: A Traditional Medical System and Its Heavy Metal Poisoning
Mohammad Mamun Sikder
Chonnam Medical Journal (2024) Vol. 60, Iss. 2, pp. 97-97
Open Access | Times Cited: 4
Evaluation of Ayush-64 (a Polyherbal Formulation) and Its Ingredients in the Syrian Hamster Model for SARS-CoV-2 Infection Reveals the Preventative Potential of Alstonia scholaris
Zaigham Abbas Rizvi, Upasna Madan, Manas Ranjan Tripathy, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1333-1333
Open Access | Times Cited: 5
Evaluating therapeutic potential of AYUSH-64 constituents against omicron variant of SARS-CoV-2 using ensemble docking and simulations
Vinod Jani, Shruti Koulgi, Mallikarjunachari Uppuladinne V N, et al.
Current Research in Structural Biology (2024) Vol. 7, pp. 100151-100151
Open Access | Times Cited: 1
Disease Characteristics, Care-Seeking Behavior, and Outcomes Associated With the Use of AYUSH-64 in COVID-19 Patients in Home Isolation in India: A Community-Based Cross-Sectional Analysis
Narayanam Srikanth, Adarsh Kumar, Bhogavalli Chandrasekhararao, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 7
Recent progress on drugs discovery study for treatment of COVID-19: repurposing existing drugs and current natural bioactive molecules
Ika Oktavianawati, Mardi Santoso, Mohd Fadzelly Abu Bakar, et al.
Applied Biological Chemistry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 2
COVID-19, its prevention and treatment in the light of Ayush medicines
Sugin Lal Jabaris S, Venkataraman Krishnamurthy, Divya Sankaramourthy
Pharmacological Research - Natural Products (2024) Vol. 3, pp. 100040-100040
Closed Access
Evaluating Personalized Add-On Ayurveda Therapy in Oxygen-Dependent Diabetic COVID-19 Patients: A 60-Day Study of Symptoms, Inflammation, and Radiological Changes
Somit Kumar, Karthikeyan Ramaraju, Mitravinda Sai Kakarla, et al.
Cureus (2024)
Open Access
Bibliometric analysis of the research publications on AYUSH-64 for COVID-19
Shyam Babu Singh, Brijesh S. Sisodia, Poornima Mansoria, et al.
International Journal of Ayurveda Research (2024) Vol. 5, Iss. 3, pp. 172-178
Closed Access
A Current Perspective of Ethnopharmacology in India
Amrita Mishra, Arun Kumar Mishra
(2024), pp. 173-190
Closed Access
A review on an ayurvedic antimalarial drug: Ayush-64
Ramakrishna Allam, S Balasundar, K.S. Divya, et al.
International Journal of Mosquito Research (2024) Vol. 11, Iss. 1, pp. 04-08
Open Access
A Prospective, Controlled, Pilot Study of Personalised Add-on Ayurveda Treatment in High-Risk Type II Diabetes COVID-19 Patients
Somit Kumar, Sujith Eranezhath, Vinod Kumar Vishwanathan, et al.
Journal of Herbal Medicine (2023) Vol. 43, pp. 100836-100836
Open Access | Times Cited: 1
Balchaturbhadra Churna as a potential medicine for SARS-CoV2 infection in pediatric setting
K. Choudhary, Saketh Ram Thrigulla, Manohar Gundeti, et al.
AYU (An International Quarterly Journal of Research in Ayurveda) (2022) Vol. 43, Iss. 4, pp. 146-158
Closed Access | Times Cited: 2
Where lies the future of Ayurveda-inspired drug discovery?
Bhushan Patwardhan
Expert Opinion on Drug Discovery (2023) Vol. 18, Iss. 9, pp. 947-949
Open Access
Navigating emerging opportunities and key considerations in Ayurvedic drug treatment
Madhu Dikshit
Journal of Drug Research in Ayurvedic Sciences (2023) Vol. 8, Iss. 4, pp. 314-315
Open Access
An open labeled, randomized, controlled clinical study to evaluate the efficacy of Torchnil capsules and Febcin tablet as add-on therapy for Covid-19 patients
Renuka Munshi, Dipti Kumbhar, Pranesh Pawaskar, et al.
Journal of Ayurveda and Integrative Medicine (2022) Vol. 13, Iss. 2, pp. 100559-100559
Open Access
Page 1

Scroll to top